ArticleScientific reports2024
A study on expression recognition based on improved mobilenetV2 network.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- MGCP-FER: Meta Control Genetic Programming (MCGP-FER) based feature extraction and fusion for facial expression recognition.Scientific reports · 2026Article
- Multimodal MRI-based two-stage artificial intelligence framework for renal fibrosis classification in chronic kidney disease.BMC nephrology · 2026Article
- Fusion of EEG feature extraction and CNN-MSTA transformer emotion recognition classification model.Scientific reports · 2025Article
- An Explainable Framework for Mental Health Monitoring Using Lightweight and Privacy-Preserving Federated Facial Emotion Recognition.Sensors (Basel, Switzerland) · 2025Article
- Exploiting deep transfer learning based precise classification and grading of renal cell carcinoma using histopathological images.Scientific reports · 2025Article
- Attention-Enhanced CNNs and transformers for accurate monkeypox and skin disease detection.Scientific reports · 2025Article
- A Lightweight Hybrid Detection System Based on the OpenMV Vision Module for an Embedded Transportation Vehicle.Sensors (Basel, Switzerland) · 2025Article
- LiSA-MobileNetV2: an extremely lightweight deep learning model with Swish activation and attention mechanism for accurate rice disease classification.Frontiers in plant science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper proposes an improved strategy for the MobileNetV2 neural network(I-MobileNetV2) in response to problems such as large parameter quantities in existing deep convolutional neural networks and the shortcomings of the lightweight neural network MobileNetV2 such as easy loss of feature information, poor real-time performance, and low accuracy rate in facial emotion recognition tasks. The network inherits the characteristics of MobilenetV2 depthwise separated convolution, signifying a reduction in computational load while maintaining a lightweight profile. It utilizes a reverse fusion mechanism to retain negative features, which makes the information less likely to be lost. The SELU activation function is used to replace the RELU6 activation function to avoid gradient vanishing. Meanwhile, to improve the feature recognition capability, the channel attention mechanism (Squeeze-and-Excitation Networks (SE-Net)) is integrated into the MobilenetV2 network. Experiments conducted on the facial expression datasets FER2013 and CK + showed that the proposed network model achieved facial expression recognition accuracies of 68.62% and 95.96%, improving upon the MobileNetV2 model by 0.72% and 6.14% respectively, and the parameter count decreased by 83.8%. These results empirically verify the effectiveness of the improvements made to the network model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.